Freestone Grove Partners LP Insulet Corp Transaction History
Freestone Grove Partners LP
- $9.71 Trillion
- Q1 2025
A detailed history of Freestone Grove Partners LP transactions in Insulet Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 108,580 shares of PODD stock, worth $35.3 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
108,580
Previous 1,594
6711.79%
Holding current value
$35.3 Million
Previous $416 Million
6751.97%
% of portfolio
0.29%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PODD
# of Institutions
791Shares Held
63.2MCall Options Held
379KPut Options Held
548K-
Vanguard Group Inc Valley Forge, PA8.67MShares$2.82 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.08MShares$1.98 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.97 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.02MShares$983 Million0.03% of portfolio
-
Baillie Gifford & CO2.25MShares$732 Million0.53% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $22.6B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...